Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|5|743-754

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.5, 2015-05, pp. : 743-754

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A first‐in‐human pharmacodynamic and pharmacokinetic study of a fully human anti‐glucagon receptor monoclonal antibody in normal healthy volunteers

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 283-291

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First‐in‐Human Dose Selection for CNTO 5825, an Anti‐Interleukin‐13 Monoclonal Antibody

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 4, 2015-10 ,pp. : 219-225

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Anti–Interleukin‐20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1438-1448

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

By  

EPILEPSIA, Vol. 56, Iss. 11, 2015-11 ,pp. : 1723-1731

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Resveratrol on the Pharmacokinetics of Carbamazepine in Healthy Human Volunteers

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 5, 2015-05 ,pp. : 701-706

John Wiley & Sons Inc

Access to resources Recommend Favorite